Funding for this research was provided by:
Innlandet Hospital Trust, Brumunddal, Norway
Lab1 AS, Sandvika, Norway
Article History
Received: 20 November 2017
Accepted: 18 January 2018
First Online: 30 January 2018
Ethics approval and consent to participate
: The study was approved by the Regional Committee for Medical and Health Research Ethics in South-eastern Norway (number 2012/966) and written informed consent was obtained from each participant.
: Not applicable.
: A.S.K. and P.G.F. declare that they have no competing interests. D.T. is the Managing Director and shareholder in Lab1, which performed the analyses of the antibodies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.